AccessPak for HIV PEP Expanded with Kaletra and Sofosbuvir and velpatasvir
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Sofosbuvir and velpatasvir and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: sofosbuvir / velpatasvir
Brand name: Epclusa
Synonyms: Sofosbuvir and Velpatasvir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Sofosbuvir Tablets
- AccessPak for HIV PEP Expanded with Kaletra-Sofosbuvir, velpatasvir, and voxilaprevir
- AccessPak for HIV PEP Expanded with Kaletra-Sojourn
- AccessPak for HIV PEP Expanded with Kaletra-Sojourn Inhalant
- AccessPak for HIV PEP Expanded with Kaletra-Solage
- AccessPak for HIV PEP Expanded with Kaletra-Solage Topical
- Sofosbuvir and velpatasvir-AccessPak for HIV PEP Expanded with Viracept
- Sofosbuvir and velpatasvir-Accolate
- Sofosbuvir and velpatasvir-Accretropin
- Sofosbuvir and velpatasvir-Accucaine
- Sofosbuvir and velpatasvir-AccuHist Drops
- Sofosbuvir and velpatasvir-AccuHist PDX Drops